Ji Lin is a seasoned medical professional with extensive experience at Abbott since 2008, currently serving as Director of Quality and Regulatory. Ji has held various leadership roles in medical affairs, focusing on clinical assay development and regulatory compliance, with noteworthy contributions including medical oversight for the development of COVID-19 EUA diagnostics and the 2022 launch of a high sensitivity troponin assay. Ji's career includes significant achievements such as successful global launches of multiple diagnostic assays, management of R&D teams, and improvements in product quality and cost efficiency, as well as a robust background in clinical studies and regulatory submissions. Ji holds a PhD in Physiology from The University of Georgia and an MD from Nanjing Medical University.
This person is not in any teams
This person is not in any offices